The role of polypeptide growth factors in recovery from stroke
- PMID: 8959227
The role of polypeptide growth factors in recovery from stroke
Abstract
In recent studies we have examined the potential role of one trophic growth factor, bFGF, in the processes of wound healing and functional recovery following experimental stroke. In studies of the endogenous expression of bFGF after focal cerebral infarction in rats, we found that bFGF gene expression was induced within 1 day and that bFGF protein levels were increased within 3 days in tissue surrounding focal infarcts. Increased bFGF expression was localized to reactive astroglia. Increased endogenous bFGF expression may contribute to neuronal survival and sprouting, glial proliferation, and new blood vessel growth (angiogenesis) in the poststroke brain. In studies of the exogenous administration of bFGF after infarction, we found that the early administration of bFGF reduces infarct size, whereas the later administration of bFGF, while not affecting infarct size, enhances functional recovery. The mechanism of this enhancement may include protection against the late retrograde death of distant neurons and/or the promotion of new neuronal sprouting and synapse formation. Basic FGF represents only one of many trophic growth factors and cytokines that are likely to act as important signaling molecules directing processes of tissue repair and functional reorganization following stroke. Our challenge in future studies is to understand the role of each of these factors singly, and in combination. One consequence of such studies should be the development of new molecular treatments to enhance recovery from stroke.
Similar articles
-
Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat.J Cereb Blood Flow Metab. 1996 Jul;16(4):542-7. doi: 10.1097/00004647-199607000-00003. J Cereb Blood Flow Metab. 1996. PMID: 8964792
-
Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke.Exp Neurol. 1999 Jul;158(1):89-96. doi: 10.1006/exnr.1999.7101. Exp Neurol. 1999. PMID: 10448420
-
Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia.Neurosci Lett. 2008 Nov 28;446(1):30-5. doi: 10.1016/j.neulet.2008.09.030. Epub 2008 Sep 19. Neurosci Lett. 2008. PMID: 18822350
-
Regenerative therapy for stroke.Cell Transplant. 2007;16(2):171-81. Cell Transplant. 2007. PMID: 17474298 Review.
-
Potential usefulness of basic fibroblast growth factor as a treatment for stroke.Cerebrovasc Dis. 1999 May-Jun;9(3):131-5. doi: 10.1159/000015941. Cerebrovasc Dis. 1999. PMID: 10207203 Review.
Cited by
-
Improved Functional Outcome After Peripheral Nerve Stimulation of the Impaired Forelimb Post-stroke.Front Neurol. 2021 Apr 20;12:610434. doi: 10.3389/fneur.2021.610434. eCollection 2021. Front Neurol. 2021. PMID: 33959086 Free PMC article.
-
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.J Clin Invest. 2000 Oct;106(7):829-38. doi: 10.1172/JCI9369. J Clin Invest. 2000. PMID: 11018070 Free PMC article.
-
Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats.Stroke. 2011 Jan;42(1):186-90. doi: 10.1161/STROKEAHA.110.590083. Epub 2010 Nov 18. Stroke. 2011. PMID: 21088244 Free PMC article.
-
Improved functional outcome after chronic stroke with delayed anti-Nogo-A therapy: A clinically relevant intention-to-treat analysis.J Cereb Blood Flow Metab. 2018 Aug;38(8):1327-1338. doi: 10.1177/0271678X17730994. Epub 2017 Sep 27. J Cereb Blood Flow Metab. 2018. PMID: 28952904 Free PMC article.
-
Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole.Brain Res. 2010 Jul 30;1346:174-82. doi: 10.1016/j.brainres.2010.05.063. Epub 2010 May 27. Brain Res. 2010. PMID: 20510888 Free PMC article.